EMIT theophylline assay at reduced cost.

Area of Science:

• Clinical Chemistry
• Analytical Chemistry
• Biochemical Assays

Background:

• Theophylline monitoring is crucial for patient care.
• Standard EMIT theophylline assays are accurate but can be costly.
• Reducing reagent expenses without compromising analytical performance is desirable.

Purpose of the Study:

• To evaluate a novel EMIT theophylline method for cost reduction.
• To assess the accuracy and precision of the new method against the standard EMIT.
• To determine the economic benefits of the new theophylline assay.

Main Methods:

• Comparative analysis of a new EMIT theophylline method versus the standard EMIT method.
• Assay of known theophylline concentrations (1.5-75 µg/ml) and clinical samples.
• Evaluation of correlation, variance, and curve stability between the two methods.

Main Results:

• A strong correlation (r = 0.997) was observed between the new and standard EMIT methods.
• The new method demonstrated comparable variance and curve stability to the standard.
• A 56% reduction in reagent expenses was achieved with the new method over 12 months.

Conclusions:

• The new EMIT theophylline method offers significant cost savings.
• The reduced-cost method maintains the high accuracy and precision of the standard EMIT assay.
• This new method presents a cost-effective alternative for theophylline therapeutic drug monitoring.